Cite

1. Abdul S, Poddar SS. A flexible technology for modified release of drugs: multi layered tablets. J Control Release. 2004;97(3):393-405.10.1016/S0168-3659(04)00186-5 Search in Google Scholar

2. Al-Zoubi N, Malamataris S. Three-layer matrix tablets and simple approach of drug release programming. J Drug Del Sci Tech. 2008; 18(6):431-37.10.1016/S1773-2247(08)50083-9 Search in Google Scholar

3. Morita R, Honda R, Takahashi Y. Development of oral controlled release preparations, a PVA swelling controlled release system (SCRS). II. In vitro and in vivo evaluation. J Control Release. 2000; 68(1):115-20.10.1016/S0168-3659(00)00244-3 Search in Google Scholar

4. Vergote GJ, Vervaet C, Van D, Hoste S, De Smed S, Demeester J, et al. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen. Int J Pharm. 2001;219(1-2):81-7.10.1016/S0378-5173(01)00628-7 Search in Google Scholar

5. More S, Ghodekar S, Rane B, Bavaskar K, Patil M, Jain A. Multilayered tablet: a novel approach for oral drug delivery. IJPSR. 2015;9(3):872-82. Search in Google Scholar

6. Dey S, Mahanti B, Khila S, Mazumder B, Gupta SD. Formulation development and optimization of bilayer tablets of aceclofenac. Expert Opin Drug Deliv. 2012;9(9):1041-50.10.1517/17425247.2012.70718722788786 Search in Google Scholar

7. Patra CN, Kumar AB, Pandit HK, Singh SP, Devi MV. Design and evaluation of sustained release bilayer tablets of propranolol hydrochloride. Acta Pharm. 2007;57(4):479-89.10.2478/v10007-007-0038-018165191 Search in Google Scholar

8. Abebe A, Akseli I, Sprockel O, Kottala N, Cuitino AM. Review of bilayer tablet technology. Int J Pharm. 2014;461(1-2):549-58.10.1016/j.ijpharm.2013.12.02824370841 Search in Google Scholar

9. Klinzing G, Zavaliangos A. Understanding the effect of environmental history on bilayer tablet interfacial shear strength. Pharm Res. 2013;30(5):1300-10.10.1007/s11095-012-0969-023334778 Search in Google Scholar

10. Anuar MS, Briscoe BJ. Interfacial elastic relaxation during the ejection of bi-layered tablets. Int J Pharm. 2010;387(1-2):42-7.10.1016/j.ijpharm.2009.11.03119963050 Search in Google Scholar

11. Wu CY, Seville JP. A comparative study of compaction properties of binary and bilayer tablets. Powder Tech. 2009;189:285-94.10.1016/j.powtec.2008.04.026 Search in Google Scholar

12. McGinity JW. Aqueous polymeric coatings for pharmaceutical dosage forms. New York: Marcel Dekker. 1997;549-70. Search in Google Scholar

13. Desai D, Wang J, Wen H, Li X, Timmins P. Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms. Pharm Dev Technol. 2013;18(6):1265-76.10.3109/10837450.2012.660699 Search in Google Scholar

14. Nirmal J, Saisivam S, Peddanna C, Muralidharan S, Godwinkumar S, Nagarajan M. Bilayer tablets of atorvastatin calcium and nicotinic acid: formulation and evaluation. Chem Pharm Bull (Tokyo). 2008; 56(10):1455-8.10.1248/cpb.56.1455 Search in Google Scholar

15. Scott DC, Hollenbeck RG. Design and manufacture of a zero-order sustained-release pellet dosage form through nonuniform drug distribution in a diffusional matrix. Pharm Res. 1991;8(2):156-61.10.1023/A:1015823532764 Search in Google Scholar

16. Shiyani B, Gattani S, Surana S. Formulation and evaluation of bi-layer tablet of metoclopramide hydrochloride and ibuprofen. AAPS Pharm Sci Tech. 2008;9(3):818-27.10.1208/s12249-008-9116-y Search in Google Scholar

17. Chidambaram N, Porter W, Flood K, Qiu Y. Formulation and characterization of new layered diffusional matrices for zero-order sustained release. J Control Release. 1998;52(1-2):149-58.10.1016/S0168-3659(97)00207-1 Search in Google Scholar

18. Conte U, Maggi L, Colombo P, La MA. Multi-layered hydrophilic matrices as constant release devices (GeomatrixTM Systems). J Control Release. 1993;26(1):39-47.10.1016/0168-3659(93)90207-L Search in Google Scholar

19. Nangia A, Molly T, Fahie BJ, Chopra SK. Novel regulated release systembased on geometric configuration. Proc Int Symp Control Release Bioactive Mater. 1995;22:294-5. Search in Google Scholar

20. Ozeki Y, Ando M, Watanabe Y, Danjo K. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets. J Control Release. 2004;95(1):51-60.10.1016/j.jconrel.2003.10.028 Search in Google Scholar

21. Shivanand P, Sprockel O. A controlled drug delivery system. Int J Pharm. 1998;167:83-96.10.1016/S0378-5173(98)00047-7 Search in Google Scholar

22. Rathbone MJ, Hadgraft J, Roberts MS. Modified-Release Drug Delivery Technology. London: Informa Healthcare. 2002:101-14.10.1201/9780203910337 Search in Google Scholar

23. Rathbone MJ, Hadgraft J, Roberts MS. Modified-Release Drug Delivery Technology. London: Informa Healthcare. 2002:59-76.10.1201/9780203910337 Search in Google Scholar

24. Bettini R, Acerbi D, Caponetti G, Musa R, Magi N, Colombo P, et al. Influence of layer position on in vitro and in vivo release of levodopa methyl ester and carbidopa from three-layer matrix tablets. Eur J Pharm Biopharm. 2002;53(2):227-32.10.1016/S0939-6411(01)00238-7 Search in Google Scholar

25. Castrati L, Mazel V, Busignies V, Diarra H, Rossi A, Tchoreloff P, et al. Comparison of breaking tests for the characterization of the interfacial strength of bilayer tablets. Int J Pharm. 2016;513(1-2): 709-16.10.1016/j.ijpharm.2016.10.005 Search in Google Scholar

26. Efentakis M, Peponaki C. Formulation study and evaluation of matrix and three-layer tablet sustained drug delivery systems based on Carbopols with isosorbite mononitrate. AAPS Pharm Sci Tech. 2008;9(3):917-23.10.1208/s12249-008-9084-2 Search in Google Scholar

27. Li SP, Karth MG, Feld KM, Dipalo LC, Pendaharkar CM, Williams RO. Evaluation of bilayer tablet machines – a case study. Drug Dev Ind Pharm. 1995;21:571-90.10.3109/03639049509048124 Search in Google Scholar

28. Vaithiyalingam SR, Sayeed VA. Critical factors in manufacturing multilay-ered tablets – assessing material attributes, in-process controls, manufacturingprocess and product performance. Int J Pharm. 2010;398:9-13.10.1016/j.ijpharm.2010.07.025 Search in Google Scholar

29. Danckwerts MP. Development of a zero-order release oral compressed tablet with potential for commercial tabletting production. Int J Pharm. 1994;112:34-45.10.1016/0378-5173(94)90259-3 Search in Google Scholar

30. Hildgen D, McMullen JN. A new gradient matrix: formulation and characterization. J Control Release. 1995;34:263-71.10.1016/0168-3659(95)00014-Y Search in Google Scholar

31. Bangalore S, Kamalakkannan G, Parkar S, Messerli FH. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120(8):713-19.10.1016/j.amjmed.2006.08.03317679131 Search in Google Scholar

32. Rathbone MJ, Hadgraft J, Roberts MS. Modified-Release Drug Delivery Technology. London: Informa Healthcare. 2002;1-19.10.1201/9780203910337 Search in Google Scholar

33. LaForce C, Gentile DA, Skoner DP. A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections. Postgrad Med. 2008;120(2):53-9.10.3810/pgm.2008.07.179118654069 Search in Google Scholar

34. Qiu Y, Chidambaram N, Flood K. Design and evaluation of layered diffusional matrices for zero-order sustained-release. J Control Release. 1998;51(2-3):123-30.10.1016/S0168-3659(97)00119-3 Search in Google Scholar

35. Yadav G, Bansak M, ThakurN, Khare SP. Multilayer tablets and their drug release kinetic models for oral controlled drug delivery system. Middle-East J Sci Res. 2013;16(6):782-95. Search in Google Scholar

36. Maroni A, Zema L, Carea M, Sangalli ME. Oral pulsatile drug delivery systems. Expert Opin Drug Deliv. 2005;2(5):855-71.10.1517/17425247.2.5.85516296783 Search in Google Scholar

37. Akseli I, Abebe A, Sprockel O, Cuitino AM. Mechanistic characterization of bilayer tablet formulations. Powder Tech. 2013; 236:30-6.10.1016/j.powtec.2012.05.048 Search in Google Scholar

38. Akseli I, Dey D, Cetinkaya C. Mechanical property characterization of bilayered tablets using nondestructive air-coupled acoustics. AAPS PharmSciTech. 2010;11(1):90-102.10.1208/s12249-009-9352-9285047920063078 Search in Google Scholar

39. Inman SJ, Briscoe BJ, Pitt KG. Topographic characterization of cellulose bilayered tablets interfaces. Chem Eng Res Dis. 2007;85(A7): 1005-12.10.1205/cherd06188 Search in Google Scholar

40. Busignies V, Mazel V, Diarra H, Tchoreloff P. Role of the elasticity of pharmaceutical materials on the interfacial mechanical strength of bilayer tablets. Int J Pharm. 2013;457(1):260-67.10.1016/j.ijpharm.2013.09.00924055440 Search in Google Scholar

41. Kottala N, Abebe A, Sprockel O, Bergum J, Nikfar F, Cuitino AM. Evaluation of the performance characteristics of bilayer tablets: Part I. Impact of material properties and process parameters on the strength of bilayer tablets. AAPS Pharm Sci Tech. 2012;13(4):1236-42.10.1208/s12249-012-9845-9351347922976242 Search in Google Scholar

42. Kottala N, Abebe A, Sprockel O, Akseli I, Nikfar F, Cuitino AM. Influence of compaction properties and interfacial topography on the performance of bilayer tablets. Int J Pharm. 2012;436(1-2):171-8.10.1016/j.ijpharm.2012.05.02622728259 Search in Google Scholar

43. Kottala N, Abebe A, Sprockel O, Akseli I, Nikfar F, Cuitino AM. Charac-terization of interfacial strength of layered powder-compacted solids. Powder Tech. 2013;239:300-7.10.1016/j.powtec.2012.12.028 Search in Google Scholar

44. Tye CK, Sun CC, Amidon GE. Evaluation of the effects of tableting speed on the relationships between compaction pressure, tablet tensile strength, and tablet solid fraction. J Pharm Sci. 2005;94(3): 465-72.10.1002/jps.2026215696587 Search in Google Scholar

45. Fell JT, Newton JM. Determination of tablet strength by the diametral-compression test. J Pharm Sci. 1970;59(5):688-91.10.1002/jps.2600590523 Search in Google Scholar

46. Wu CY, Best SM, Bentham AC, Hancock BC, Bonfield W. Predicting the tensile strength of compacted multi-component mixtures of pharmaceutical powders. Pharm Res. 2006;23(8):1898-1905.10.1007/s11095-006-9005-6 Search in Google Scholar

47. Dietrich P, Bauer-Brandl A, Schubert R. Influence of tableting forces and lubricant concentration on the adhesion strength in complex layer tablets. Drug Dev Ind Pharm. 2000;26(7):745-54.10.1081/DDC-100101293 Search in Google Scholar

48. Malaterre V, Metz H, Ogorka J, Gurny R, Loggia N, Mader K. Benchtop-magnetic resonance imaging (BT-MRI) characterization of push-pull osmotic controlled release systems. J Control Release. 2009;133(1):31-6.10.1016/j.jconrel.2008.09.007 Search in Google Scholar

49. Niwa M, Hiraishi Y, Iwasaki N, Terada K. Quantitative analysis of the layer separation risk in bilayer tablets using terahertz pulsed imaging. Int J Pharm. 2013;452(1-2):249-56.10.1016/j.ijpharm.2013.05.010 Search in Google Scholar

50. Podczeck F. Theoretical and experimental investigations into the delamination tendencies of bilayer tablets. Int J Pharm. 2011; 408(1-2):102-12.10.1016/j.ijpharm.2011.02.007 Search in Google Scholar

51. Yang L, Venkatesh G, Fassihi R. Compaction simulator study of a novel triple-layer tablet matrix for industrial tableting. Int J Pharm. 1997;152:45-52.10.1016/S0378-5173(97)04911-9 Search in Google Scholar

52. Karehill PG, Glaser M, Nystrom C. Studies on direct compression of tablets. XXIII. The importance of surface roughness for the compactability of some directly compressible materials with different bonding and volume reduction properties. Int J Pharm. 1990;64:35-43.10.1016/0378-5173(90)90176-5 Search in Google Scholar

53. Busignies V, Mazel V, Diarra H, Tchoreloff P. Development of a new test for the easy characterization of the adhesion at the interface of bilayer tablets: proof-of-concept study by experimental design. Int J Pharm. 2014;477(1-2):476-84.10.1016/j.ijpharm.2014.10.05125445527 Search in Google Scholar

54. Takeuchi H, Yasuji T, Yamamoto H, Kawashima Y. Spray-dried lactose composite particles containing an ion complex of alginate-chitosan for designing a dry-coated tablet having a time-controlled releasing function. Pharm Res. 2000;17(1):94-9.10.1023/A:1007530927887 Search in Google Scholar

55. Podczeck F, Drake KR, Newton JM, Haririan I. The strength of bilayered tablets. Eur J Pharm Sci. 2006;29(5):361-6.10.1016/j.ejps.2006.07.00516950605 Search in Google Scholar

56. Podczeck F, Al-Muti E. The tensile strength of bilayered tablets made from different grades of microcrystalline cellulose. Eur J Pharm Sci. 2010;41(3-4):483-8.10.1016/j.ejps.2010.08.00220696243 Search in Google Scholar

57. Picker KM. Time dependence of elastic recovery for characterization of tableting materials. Pharm Dev Technol. 2001;6(1):61-70.10.1081/PDT-10000001411247276 Search in Google Scholar

58. Goutte F, Guemguem F, Dragan C, Vergnault G, Wehrle P. Power of experimental design studies for the validation of pharmaceutical processes: case study of a multilayer tablet manufacturing process. Drug Dev Ind Pharm. 2002;28(7):841-8.10.1081/DDC-120005630 Search in Google Scholar

59. Sugisawa K, Kaneko T, Sago T, Sato T. Rapid quantitative analysis of magnesium stearate in pharmaceutical powders and solid dosage forms by atomic absorption: method development and application in product manufacturing. J Pharm Biomed Anal. 2009;49(3):858-61.10.1016/j.jpba.2009.01.00419195812 Search in Google Scholar

60. Yamamura T, Ohta T, Taira T, Ogawa Y, Sakai Y, Moribe K et al. Effects of automated external lubrication on tablet properties and the stability of eprazinone hydrochloride. Int J Pharm. 2009;370(1-2):1-7.10.1016/j.ijpharm.2008.11.00719059327 Search in Google Scholar

61. Cremer K, Asmussen B. Novel controlled-release tablet with erodible layers. Proc Int Control Release Bioact Mater. 1995;22:732-3. Search in Google Scholar

62. Dietrich P, Cremer K, Bauer-Brandl A, Schubert R. Complex layer tablets-aspects of a new tabletting technology. Pharm Sci. 1998;1(1):318. Search in Google Scholar

63. Dietrich P, Cremer K, Bauer-Brandl A, Schubert R. Adhesion strength in two-layer tablets. Pharm Res. 1997;14(11):429. Search in Google Scholar

eISSN:
2300-6676
Language:
English
Publication timeframe:
4 times per year
Journal Subjects:
Medicine, Clinical Medicine, other, Pharmacology, Toxicology, Pharmacy